Healthequity (HQY) Non-Current Deffered Revenue (2014 - 2019)

Healthequity has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $3.0 million in Q1 2019.

• On a quarterly basis, Non-Current Deffered Revenue rose 23.92% year-over-year to $3.0 million in Q1 2019; TTM through Jan 2019 was $3.0 million, a 23.92% increase from a year earlier, with the FY2019 full-year figure at $3.0 million, up 23.92% from the prior year.
• Non-Current Deffered Revenue was $3.0 million for Q1 2019 at Healthequity, up from $2.5 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $3.0 million in Q1 2019, with the low at $145000.0 in Q3 2015.
• Average Non-Current Deffered Revenue over 5 years is $1.3 million, with a median of $1.3 million recorded in 2016.
• The sharpest annual moves came in 2015 and 2016: Non-Current Deffered Revenue sank 66.67% in 2015, then soared 642.07% in 2016.
• Over 5 years, Non-Current Deffered Revenue stood at $195000.0 in 2015, then jumped by 564.1% to $1.3 million in 2016, then surged by 71.89% to $2.2 million in 2017, then increased by 10.78% to $2.5 million in 2018, then rose by 20.36% to $3.0 million in 2019.
• The last three Non-Current Deffered Revenue figures came in at $3.0 million (Q1 2019), $2.5 million (Q2 2018), and $2.4 million (Q1 2018), per Business Quant data.